170 related articles for article (PubMed ID: 30837611)
1. Striatal Interneurons in Transgenic Nonhuman Primate Model of Huntington's Disease.
Lallani SB; Villalba RM; Chen Y; Smith Y; Chan AWS
Sci Rep; 2019 Mar; 9(1):3528. PubMed ID: 30837611
[TBL] [Abstract][Full Text] [Related]
2. Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.
Mehler MF; Petronglo JR; Arteaga-Bracho EE; Gulinello ME; Winchester ML; Pichamoorthy N; Young SK; DeJesus CD; Ishtiaq H; Gokhan S; Molero AE
J Neurosci; 2019 Mar; 39(10):1892-1909. PubMed ID: 30626701
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
Cho IK; Yang B; Forest C; Qian L; Chan AWS
PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
[TBL] [Abstract][Full Text] [Related]
4. Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons.
Picconi B; Passino E; Sgobio C; Bonsi P; Barone I; Ghiglieri V; Pisani A; Bernardi G; Ammassari-Teule M; Calabresi P
Neurobiol Dis; 2006 Apr; 22(1):143-52. PubMed ID: 16326108
[TBL] [Abstract][Full Text] [Related]
5. Thalamostriatal degeneration contributes to dystonia and cholinergic interneuron dysfunction in a mouse model of Huntington's disease.
Crevier-Sorbo G; Rymar VV; Crevier-Sorbo R; Sadikot AF
Acta Neuropathol Commun; 2020 Feb; 8(1):14. PubMed ID: 32033588
[TBL] [Abstract][Full Text] [Related]
6. A two years longitudinal study of a transgenic Huntington disease monkey.
Chan AW; Xu Y; Jiang J; Rahim T; Zhao D; Kocerha J; Chi T; Moran S; Engelhardt H; Larkin K; Neumann A; Cheng H; Li C; Nelson K; Banta H; Zola SM; Villinger F; Yang J; Testa CM; Mao H; Zhang X; Bachevalier J
BMC Neurosci; 2014 Mar; 15():36. PubMed ID: 24581271
[TBL] [Abstract][Full Text] [Related]
7. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
Huot P; Lévesque M; Parent A
Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
[TBL] [Abstract][Full Text] [Related]
8. Progress in developing transgenic monkey model for Huntington's disease.
Snyder BR; Chan AWS
J Neural Transm (Vienna); 2018 Mar; 125(3):401-417. PubMed ID: 29127484
[TBL] [Abstract][Full Text] [Related]
9. Neuronal vulnerability in mouse models of Huntington's disease: membrane channel protein changes.
Ariano MA; Wagle N; Grissell AE
J Neurosci Res; 2005 Jun; 80(5):634-45. PubMed ID: 15880743
[TBL] [Abstract][Full Text] [Related]
10. Brain urea increase is an early Huntington's disease pathogenic event observed in a prodromal transgenic sheep model and HD cases.
Handley RR; Reid SJ; Brauning R; Maclean P; Mears ER; Fourie I; Patassini S; Cooper GJS; Rudiger SR; McLaughlan CJ; Verma PJ; Gusella JF; MacDonald ME; Waldvogel HJ; Bawden CS; Faull RLM; Snell RG
Proc Natl Acad Sci U S A; 2017 Dec; 114(52):E11293-E11302. PubMed ID: 29229845
[TBL] [Abstract][Full Text] [Related]
11. Transient global ischemia in rats yields striatal projection neuron and interneuron loss resembling that in Huntington's disease.
Meade CA; Figueredo-Cardenas G; Fusco F; Nowak TS; Pulsinelli WA; Reiner A
Exp Neurol; 2000 Dec; 166(2):307-23. PubMed ID: 11085896
[TBL] [Abstract][Full Text] [Related]
12. Cholinergic interneurons in the Q140 knockin mouse model of Huntington's disease: Reductions in dendritic branching and thalamostriatal input.
Deng YP; Reiner A
J Comp Neurol; 2016 Dec; 524(17):3518-3529. PubMed ID: 27219491
[TBL] [Abstract][Full Text] [Related]
13. Striatal parvalbuminergic neurons are lost in Huntington's disease: implications for dystonia.
Reiner A; Shelby E; Wang H; Demarch Z; Deng Y; Guley NH; Hogg V; Roxburgh R; Tippett LJ; Waldvogel HJ; Faull RL
Mov Disord; 2013 Oct; 28(12):1691-9. PubMed ID: 24014043
[TBL] [Abstract][Full Text] [Related]
14. Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease.
Fusco FR; Chen Q; Lamoreaux WJ; Figueredo-Cardenas G; Jiao Y; Coffman JA; Surmeier DJ; Honig MG; Carlock LR; Reiner A
J Neurosci; 1999 Feb; 19(4):1189-202. PubMed ID: 9952397
[TBL] [Abstract][Full Text] [Related]
15. Striatal interneurons in Huntington's disease: selective increase in the density of calretinin-immunoreactive medium-sized neurons.
Cicchetti F; Parent A
Mov Disord; 1996 Nov; 11(6):619-26. PubMed ID: 8914086
[TBL] [Abstract][Full Text] [Related]
16. Disrupted striatal neuron inputs and outputs in Huntington's disease.
Reiner A; Deng YP
CNS Neurosci Ther; 2018 Apr; 24(4):250-280. PubMed ID: 29582587
[TBL] [Abstract][Full Text] [Related]
17. Cell type-specific localization of optineurin in the striatal neurons of mice: implications for neuronal vulnerability in Huntington's disease.
Okita S; Morigaki R; Koizumi H; Kaji R; Nagahiro S; Goto S
Neuroscience; 2012 Jan; 202():363-70. PubMed ID: 22155493
[TBL] [Abstract][Full Text] [Related]
18. Cholinergic deficits selectively boost cortical intratelencephalic control of striatum in male Huntington's disease model mice.
Pancani T; Day M; Tkatch T; Wokosin DL; González-Rodríguez P; Kondapalli J; Xie Z; Chen Y; Beaumont V; Surmeier DJ
Nat Commun; 2023 Mar; 14(1):1398. PubMed ID: 36914640
[TBL] [Abstract][Full Text] [Related]
19. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease.
Hughes PE; Alexi T; Williams CE; Clark RG; Gluckman PD
Neuroscience; 1999; 92(1):197-209. PubMed ID: 10392842
[TBL] [Abstract][Full Text] [Related]
20. In Vivo Multidimensional Brain Imaging in Huntington's Disease Animal Models.
Flament J; Hantraye P; Valette J
Methods Mol Biol; 2018; 1780():285-301. PubMed ID: 29856025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
